Literature DB >> 28655595

Diabetes of the exocrine pancreas: American Diabetes Association-compliant lexicon.

Maxim S Petrov1.   

Abstract

Multidisciplinary teams, including gastroenterologists, endocrinologists, surgeons, dietitians, primary care physicians, and other health professionals, are involved in management of individuals with diabetes of the exocrine pancreas (DEP). This necessitates introduction of a uniform terminology to ensure proper communication and reporting. Because DEP is a form of secondary diabetes mellitus, it makes sense to align the evolving DEP lexicon with nomenclature and diagnostic standards advocated by a world leading professional body in the field of diabetes such as the American Diabetes Association. This Editorial offers a historical excursus on the terms used and proposes a new concise nomenclature and diagnostic criteria. This new taxonomy of DEP, compliant with the American Diabetes Association standards of diagnosis and care for patients with diabetes mellitus, will ensure standardisation of reporting in future clinical studies on DEP and enable a dynamic incorporation of glucose dysregulation mechanisms related specifically to diseases of the exocrine pancreas as new evidence emerges.
Copyright © 2017 IAP and EPC. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute pancreatitis; Chronic pancreatitis; Cystic fibrosis; Diabetes mellitus; Pancreatic cancer

Year:  2017        PMID: 28655595     DOI: 10.1016/j.pan.2017.06.007

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  24 in total

1.  Antidiabetic Medications and Mortality Risk in Individuals With Pancreatic Cancer-Related Diabetes and Postpancreatitis Diabetes: A Nationwide Cohort Study.

Authors:  Jaelim Cho; Robert Scragg; Stephen J Pandol; Mark O Goodarzi; Maxim S Petrov
Journal:  Diabetes Care       Date:  2019-06-21       Impact factor: 19.112

2.  Relationship between circulating levels of pancreatic proteolytic enzymes and pancreatic hormones.

Authors:  Sakina H Bharmal; Sayali A Pendharkar; Ruma G Singh; Mark O Goodarzi; Stephen J Pandol; Maxim S Petrov
Journal:  Pancreatology       Date:  2017-09-20       Impact factor: 3.996

3.  Skeletal muscle: A new piece in the pancreatitis puzzle.

Authors:  Maxim S Petrov
Journal:  United European Gastroenterol J       Date:  2019-12-01       Impact factor: 4.623

4.  Pro-inflammatory cytokines after an episode of acute pancreatitis: associations with fasting gut hormone profile.

Authors:  Sayali A Pendharkar; Ruma G Singh; Shayal K Chand; Aya Cervantes; Maxim S Petrov
Journal:  Inflamm Res       Date:  2017-12-29       Impact factor: 4.575

Review 5.  Intra-pancreatic fat deposition: bringing hidden fat to the fore.

Authors:  Maxim S Petrov; Roy Taylor
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-12-08       Impact factor: 46.802

Review 6.  Pancreas image mining: a systematic review of radiomics.

Authors:  Bassam M Abunahel; Beau Pontre; Haribalan Kumar; Maxim S Petrov
Journal:  Eur Radiol       Date:  2020-11-05       Impact factor: 5.315

7.  African-Americans and Indigenous Peoples Have Increased Burden of Diseases of the Exocrine Pancreas: A Systematic Review and Meta-Analysis.

Authors:  Aya Cervantes; Ellen K Waymouth; Maxim S Petrov
Journal:  Dig Dis Sci       Date:  2018-09-27       Impact factor: 3.199

Review 8.  Tobacco and alcohol as risk factors for pancreatic cancer.

Authors:  Murray Korc; Christie Y Jeon; Mouad Edderkaoui; Stephen J Pandol; Maxim S Petrov
Journal:  Best Pract Res Clin Gastroenterol       Date:  2017-09-06       Impact factor: 3.043

9.  Continuous Glucose Monitoring for the Detection of Hypoglycemia in Patients With Diabetes of the Exocrine Pancreas.

Authors:  Channabasappa Shivaprasad; Kolla Gautham; Kejal Shah; Soumya Gupta; Preethika Palani; Biswas Anupam
Journal:  J Diabetes Sci Technol       Date:  2020-12-16

Review 10.  Global epidemiology and holistic prevention of pancreatitis.

Authors:  Maxim S Petrov; Dhiraj Yadav
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-03       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.